ARCHIVES

FDA Tightens Conflict of Interest Rules For Advisors.

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | March 23, 2007

Download PDF Visit The Full Archive

Related Articles

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992

ACS Cancer Response System Budget Request Total $185,140

August 9, 1985

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

May 30, 1975

In Brief: City of Hope Wins $5.5M Grant From NIA; Comis To Head Group Chairmen’s Committee

November 23, 1997

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985